AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Onychomycosis Clinical Trial Pipeline Highlights 2021 - ResearchAndMarkets.com

March 24, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Mar 24, 2021--

The “Global Onychomycosis Clinical Trial Pipeline Highlights - 2021” report has been added to ResearchAndMarkets.com’s offering.

Onychomycosis Pipeline Highlights - 2021, provides the most up-to-date information on key pipeline products in the global Onychomycosis market.

ADVERTISEMENT

It covers emerging therapies for Onychomycosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Onychomycosis pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Onychomycosis pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Onychomycosis pipeline products by the company.

Short-term Launch Highlights:

Find out which Onychomycosis pipeline products will be launched in the US and Ex-US till 2025.

SUMMARY:

  • Onychomycosis phase 3 clinical trial pipeline products
  • Onychomycosis phase 2 clinical trial pipeline products
  • Onychomycosis phase 1 clinical trial pipeline products
  • Onychomycosis preclinical research pipeline products
  • Onychomycosis discovery stage pipeline products
  • Onychomycosis pipeline products short-term launch highlights

Key Topics Covered:

1. Onychomycosis Pipeline by Stages

2. Onychomycosis Phase 3 Clinical Trial Insights

3. Onychomycosis Phase 2 Clinical Trial Insights

4. Onychomycosis Phase 1 Clinical Trial Insights

5. Onychomycosis Preclinical Research Insights

6. Onychomycosis Discovery Stage Insights

ADVERTISEMENT

7. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/jyremi.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210324005820/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: GENERAL HEALTH OTHER HEALTH HEALTH CLINICAL TRIALS MANAGED CARE

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 03/24/2021 01:20 PM/DISC: 03/24/2021 01:21 PM

http://www.businesswire.com/news/home/20210324005820/en